204 related articles for article (PubMed ID: 31095958)
1. Enhancing Tumor Drug Distribution With Ultrasound-Triggered Nanobubbles.
Nittayacharn P; Yuan HX; Hernandez C; Bielecki P; Zhou H; Exner AA
J Pharm Sci; 2019 Sep; 108(9):3091-3098. PubMed ID: 31095958
[TBL] [Abstract][Full Text] [Related]
2. Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy.
Rapoport N; Gao Z; Kennedy A
J Natl Cancer Inst; 2007 Jul; 99(14):1095-106. PubMed ID: 17623798
[TBL] [Abstract][Full Text] [Related]
3. Enhanced tumor delivery and antitumor response of doxorubicin-loaded albumin nanoparticles formulated based on a Schiff base.
Li F; Zheng C; Xin J; Chen F; Ling H; Sun L; Webster TJ; Ming X; Liu J
Int J Nanomedicine; 2016; 11():3875-90. PubMed ID: 27574421
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of prostate cancer growth using doxorubicin assisted by ultrasound-targeted nanobubble destruction.
Fan X; Wang L; Guo Y; Xiong X; Zhu L; Fang K
Int J Nanomedicine; 2016; 11():3585-96. PubMed ID: 27536100
[TBL] [Abstract][Full Text] [Related]
5. Charge-reversal-functionalized PLGA nanobubbles as theranostic agents for ultrasonic-imaging-guided combination therapy.
Yang H; Shen X; Yan J; Xie X; Chen Z; Li T; Li S; Qin X; Wu C; Liu Y
Biomater Sci; 2018 Aug; 6(9):2426-2439. PubMed ID: 30040100
[TBL] [Abstract][Full Text] [Related]
6. Ultrasound-triggered therapeutic microbubbles enhance the efficacy of cytotoxic drugs by increasing circulation and tumor drug accumulation and limiting bioavailability and toxicity in normal tissues.
Ingram N; McVeigh LE; Abou-Saleh RH; Maynard J; Peyman SA; McLaughlan JR; Fairclough M; Marston G; Valleley EMA; Jimenez-Macias JL; Charalambous A; Townley W; Haddrick M; Wierzbicki A; Wright A; Volpato M; Simpson PB; Treanor DE; Thomson NH; Loadman PM; Bushby RJ; Johnson BRG; Jones PF; Evans JA; Freear S; Markham AF; Evans SD; Coletta PL
Theranostics; 2020; 10(24):10973-10992. PubMed ID: 33042265
[TBL] [Abstract][Full Text] [Related]
7. Efficient ultrasound-mediated drug delivery to orthotopic liver tumors - Direct comparison of doxorubicin-loaded nanobubbles and microbubbles.
Nittayacharn P; Abenojar E; Cooley MB; Berg FM; Counil C; Sojahrood AJ; Khan MS; Yang C; Berndl E; Golczak M; Kolios MC; Exner AA
J Control Release; 2024 Mar; 367():135-147. PubMed ID: 38237687
[TBL] [Abstract][Full Text] [Related]
8. Ultrasound-mediated cavitation enhances the delivery of an EGFR-targeting liposomal formulation designed for chemo-radionuclide therapy.
Thomas E; Menon JU; Owen J; Skaripa-Koukelli I; Wallington S; Gray M; Mannaris C; Kersemans V; Allen D; Kinchesh P; Smart S; Carlisle R; Vallis KA
Theranostics; 2019; 9(19):5595-5609. PubMed ID: 31534505
[TBL] [Abstract][Full Text] [Related]
9. Using acoustic cavitation to enhance chemotherapy of DOX liposomes: experiment in vitro and in vivo.
Zhao YZ; Dai DD; Lu CT; Lv HF; Zhang Y; Li X; Li WF; Wu Y; Jiang L; Li XK; Huang PT; Chen LJ; Lin M
Drug Dev Ind Pharm; 2012 Sep; 38(9):1090-8. PubMed ID: 22188116
[TBL] [Abstract][Full Text] [Related]
10. Intratumoral Distribution and pH-Dependent Drug Release of High Molecular Weight HPMA Copolymer Drug Conjugates Strongly Depend on Specific Tumor Substructure and Microenvironment.
Noack AK; Lucas H; Chytil P; Etrych T; Mäder K; Mueller T
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825790
[TBL] [Abstract][Full Text] [Related]
11. Perfusion-guided sonopermeation of neuroblastoma: a novel strategy for monitoring and predicting liposomal doxorubicin uptake
Bellary A; Villarreal A; Eslami R; Undseth QJ; Lec B; Defnet AM; Bagrodia N; Kandel JJ; Borden MA; Shaikh S; Chopra R; Laetsch TW; Delaney LJ; Shaw CM; Eisenbrey JR; Hernandez SL; Sirsi SR
Theranostics; 2020; 10(18):8143-8161. PubMed ID: 32724463
[TBL] [Abstract][Full Text] [Related]
12. Optimizing the Design of Blood-Brain Barrier-Penetrating Polymer-Lipid-Hybrid Nanoparticles for Delivering Anticancer Drugs to Glioblastoma.
Ahmed T; Liu FF; He C; Abbasi AZ; Cai P; Rauth AM; Henderson JT; Wu XY
Pharm Res; 2021 Nov; 38(11):1897-1914. PubMed ID: 34655006
[TBL] [Abstract][Full Text] [Related]
13. Magnetic Targeting and Ultrasound Activation of Liposome-Microbubble Conjugate for Enhanced Delivery of Anticancer Therapies.
Dwivedi P; Kiran S; Han S; Dwivedi M; Khatik R; Fan R; Mangrio FA; Du K; Zhu Z; Yang C; Huang F; Ejaz A; Han R; Si T; Xu RX
ACS Appl Mater Interfaces; 2020 May; 12(21):23737-23751. PubMed ID: 32374147
[TBL] [Abstract][Full Text] [Related]
14. Dual-targeted and pH-sensitive Doxorubicin Prodrug-Microbubble Complex with Ultrasound for Tumor Treatment.
Luo W; Wen G; Yang L; Tang J; Wang J; Wang J; Zhang S; Zhang L; Ma F; Xiao L; Wang Y; Li Y
Theranostics; 2017; 7(2):452-465. PubMed ID: 28255342
[TBL] [Abstract][Full Text] [Related]
15. Using Peptide Aptamer Targeted Polymers as a Model Nanomedicine for Investigating Drug Distribution in Cancer Nanotheranostics.
Zhao Y; Houston ZH; Simpson JD; Chen L; Fletcher NL; Fuchs AV; Blakey I; Thurecht KJ
Mol Pharm; 2017 Oct; 14(10):3539-3549. PubMed ID: 28880092
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer-lipid hybrid nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer.
Wong HL; Bendayan R; Rauth AM; Wu XY
J Control Release; 2006 Dec; 116(3):275-84. PubMed ID: 17097178
[TBL] [Abstract][Full Text] [Related]
17. Opto-acoustic synergistic irradiation for vaporization of natural melanin-cored nanodroplets at safe energy levels and efficient sono-chemo-photothermal cancer therapy.
Hu Y; Xue S; Long T; Lyu P; Zhang X; Chen J; Chen S; Liu C; Chen X
Theranostics; 2020; 10(23):10448-10465. PubMed ID: 32929359
[No Abstract] [Full Text] [Related]
18. Preparation Of Nanobubbles Modified With A Small-Molecule CXCR4 Antagonist For Targeted Drug Delivery To Tumors And Enhanced Ultrasound Molecular Imaging.
Peng Y; Zhu L; Wang L; Liu Y; Fang K; Lan M; Shen D; Liu D; Yu Z; Guo Y
Int J Nanomedicine; 2019; 14():9139-9157. PubMed ID: 32063704
[TBL] [Abstract][Full Text] [Related]
19. Tumor targeting efficiency of bare nanoparticles does not mean the efficacy of loaded anticancer drugs: importance of radionuclide imaging for optimization of highly selective tumor targeting polymeric nanoparticles with or without drug.
Lee BS; Park K; Park S; Kim GC; Kim HJ; Lee S; Kil H; Oh SJ; Chi D; Kim K; Choi K; Kwon IC; Kim SY
J Control Release; 2010 Oct; 147(2):253-60. PubMed ID: 20624433
[TBL] [Abstract][Full Text] [Related]
20. Hydrophobically modified polysaccharide-based on polysialic acid nanoparticles as carriers for anticancer drugs.
Jung B; Shim MK; Park MJ; Jang EH; Yoon HY; Kim K; Kim JH
Int J Pharm; 2017 Mar; 520(1-2):111-118. PubMed ID: 28179099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]